Abbott Laboratories (NYSE:ABT)
| 122.24 BATS BZX Real-Time Price As of 10:56am ET |  +1.32 / +1.09%Today’s Change | 98.67 Today|||52-Week Range 128.54 | +11.64% Year-to-Date |
Latest ABT News | Press Releases
Today’s Trading
| Previous close | 120.92 |
| Today’s open | 121.31 |
| Day’s range | 121.08 - 122.55 |
| Volume | 977,671 |
| Average volume (3 months) | 5,908,614 |
| Market cap | $215.0B |
Data as of 10:56am ET, 08/03/2021
Growth & Valuation
| Earnings growth (last year) | +21.67% |
| Earnings growth (this year) | +21.49% |
| Earnings growth (next 5 years) | +12.34% |
| Revenue growth (last year) | +8.48% |
| P/E ratio | 38.3 |
| Price/Sales | 5.65 |
| Price/Book | 6.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +0.24 | +0.09% |
| BSXBoston Scientific Co... | -0.58 | -1.26% |
| DXCMDexcom Inc | +4.85 | +0.95% |
| BAXBaxter International... | -0.53 | -0.69% |
Data as of 10:56am ET, 08/03/2021
Financials
| Next reporting date | October 20, 2021 |
| EPS forecast (this quarter) | $0.93 |
| Annual revenue (last year) | $34.6B |
| Annual profit (last year) | $4.5B |
| Net profit margin | 12.86% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
